Skip to main content
Top
Published in: International Urology and Nephrology 6/2016

01-06-2016 | Nephrology - Original Paper

Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients

Authors: Radojica V. Stolic, Goran Z. Trajkovic, Mirjana M. Kostic, Sasa R. Sovtic, Andrijana M. Odalovic, Biljana D. Krdzic, Maja V. Sipic, Snezana Lazic, Zorica N. Sojevic-Timotijevic

Published in: International Urology and Nephrology | Issue 6/2016

Login to get access

Abstract

Purpose

The number of elderly patients with end-stage kidney disease is on the rise. Nonalcoholic fatty liver disease (NAFLD) is characterized by parenchymal fat accumulation in patients without information about alcohol abuse. The aim of our study was to determine correlation between NAFLD and cardiovascular diseases in elderly hemodialysis patients.

Methods

The examination was organized as observational and cross-sectional study in elderly patients on hemodialysis. An abdominal ultrasound examination was made in order to define NAFLD. Intima-media thickness of the carotid arteries was quantified by Doppler ultrasound. Biochemical parameters, gender, anthropometric characteristics, duration, adequacy of hemodialysis, blood pressure, smoking and cardiovascular disease were determined. Respondents were divided into a group with NAFLD (37/72 patients, 51 %) and group without NAFLD (35/72 patients, 49 %).

Results

Patients with NAFLD have significantly more cardiovascular disease (p = 0.017) as well as significantly higher values of intima-media thickness of the carotid arteries (p = 0.03) in correlation with patients without NAFLD. Patients without NAFLD have a statistically lower triglyceride (p = 0.04), aspartate aminotransferase (p = 0.006), alanine aminotransferase (p = 0.013) and gamma-glutamyl transpeptidase (p = 0.029) compared to patients with NAFLD. Patients with cardiovascular disease have a higher risk of NAFLD; likewise, patients with NAFLD have a three times higher chance for developing cardiovascular diseases (OR 3.01).

Conclusion

Elderly patients on hemodialysis with cardiovascular disease have a higher risk of NAFLD; likewise, patients with NAFLD have a three times higher chance for developing cardiovascular diseases.
Literature
2.
go back to reference Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD (2003) The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 60:352–360CrossRefPubMed Jager KJ, van Dijk PC, Dekker FW, Stengel B, Simpson K, Briggs JD (2003) The epidemic of aging in renal replacement therapy: an update on elderly patients and their outcomes. Clin Nephrol 60:352–360CrossRefPubMed
3.
go back to reference Kurella M, Covinsky KE, Collins AJ, Chertow GM (2007) Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146:177–183CrossRefPubMed Kurella M, Covinsky KE, Collins AJ, Chertow GM (2007) Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146:177–183CrossRefPubMed
4.
go back to reference Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM et al (2008) Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103:2263–2271CrossRefPubMedPubMedCentral Dunn W, Xu R, Wingard DL, Rogers C, Angulo P, Younossi ZM et al (2008) Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 103:2263–2271CrossRefPubMedPubMedCentral
5.
go back to reference Serfaty L, Lemoine M (2008) Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab 34:634–637CrossRefPubMed Serfaty L, Lemoine M (2008) Definition and natural history of metabolic steatosis: clinical aspects of NAFLD, NASH and cirrhosis. Diabetes Metab 34:634–637CrossRefPubMed
6.
go back to reference Vuppalanchi R, Chalasani N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49:306–317CrossRefPubMedPubMedCentral Vuppalanchi R, Chalasani N (2009) Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: selected practical issues in their evaluation and management. Hepatology 49:306–317CrossRefPubMedPubMedCentral
7.
go back to reference Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ (2008) Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 14:2474–2486CrossRefPubMedPubMedCentral Schreuder TC, Verwer BJ, van Nieuwkerk CM, Mulder CJ (2008) Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment. World J Gastroenterol 14:2474–2486CrossRefPubMedPubMedCentral
9.
go back to reference Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Rodella S et al (2013) Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One 8(2):CD57183. doi:10.1371/journal.pone.0057183 CrossRef Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Rodella S et al (2013) Non-alcoholic fatty liver disease is associated with an increased incidence of atrial fibrillation in patients with type 2 diabetes. PLoS One 8(2):CD57183. doi:10.​1371/​journal.​pone.​0057183 CrossRef
10.
go back to reference Neri S, Signorelli SS, Scuderi R, Bruno M, Bertino G, Clementi A et al (2011) Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease. Int J Angiol 20:149–156CrossRefPubMedPubMedCentral Neri S, Signorelli SS, Scuderi R, Bruno M, Bertino G, Clementi A et al (2011) Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic fatty liver disease. Int J Angiol 20:149–156CrossRefPubMedPubMedCentral
12.
go back to reference Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G et al (2008) Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 121:72–78CrossRefPubMed Fracanzani AL, Burdick L, Raselli S, Pedotti P, Grigore L, Santorelli G et al (2008) Carotid artery intima-media thickness in nonalcoholic fatty liver disease. Am J Med 121:72–78CrossRefPubMed
13.
go back to reference Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMed
14.
go back to reference Daugirdas JT (1994) Chronic haemodialysis prescription: a urea kinetics approach. In: Daugirdas J, Ing TS (eds) Handbook of dialysis. Little Brown, Boston, pp 92–120 Daugirdas JT (1994) Chronic haemodialysis prescription: a urea kinetics approach. In: Daugirdas J, Ing TS (eds) Handbook of dialysis. Little Brown, Boston, pp 92–120
15.
go back to reference Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterol 123:745–750CrossRef Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M et al (2002) The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterol 123:745–750CrossRef
16.
go back to reference Saverymuttu SH, Joseph AE, Maxwell JD (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292:13–15CrossRef Saverymuttu SH, Joseph AE, Maxwell JD (1986) Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J (Clin Res Ed) 292:13–15CrossRef
17.
go back to reference Tahmasebpour HR, Buckley AR, Cooperberg PL, Fix CH (2005) Sonographic examination of the carotid arteries. Radiographics 25:1561–1575CrossRefPubMed Tahmasebpour HR, Buckley AR, Cooperberg PL, Fix CH (2005) Sonographic examination of the carotid arteries. Radiographics 25:1561–1575CrossRefPubMed
18.
go back to reference Franco MRG, Fernandes NMS (2012) Dialysis in the elderly patient: a challenge of the XXI century narrative review. J Bras Nefrol 34:132–141 Franco MRG, Fernandes NMS (2012) Dialysis in the elderly patient: a challenge of the XXI century narrative review. J Bras Nefrol 34:132–141
19.
go back to reference Sass DA, Chang P, Chopra KB (2005) Nonalcoholic fatty liver disease: a clinical review. Digest Dis Sci 50:171–180CrossRefPubMed Sass DA, Chang P, Chopra KB (2005) Nonalcoholic fatty liver disease: a clinical review. Digest Dis Sci 50:171–180CrossRefPubMed
20.
go back to reference Paul J, Dasgupta S, Ghosh MK, Shaw K, Roy KS, Niyogi SM (2012) A study of atherosclerosis in patients with chronic renal failure with special reference to carotid artery intima media thickness. Heart Views 13:91–96CrossRefPubMedPubMedCentral Paul J, Dasgupta S, Ghosh MK, Shaw K, Roy KS, Niyogi SM (2012) A study of atherosclerosis in patients with chronic renal failure with special reference to carotid artery intima media thickness. Heart Views 13:91–96CrossRefPubMedPubMedCentral
21.
go back to reference Targher G, Bertolini L, Padovani R, Zoppini G, Zenari L, Falezza G (2005) Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Arterioscler Thromb Vasc Biol 25:2687–2688CrossRefPubMed Targher G, Bertolini L, Padovani R, Zoppini G, Zenari L, Falezza G (2005) Associations between liver histology and carotid intima-media thickness in patients with nonalcoholic fatty liver disease. Arterioscler Thromb Vasc Biol 25:2687–2688CrossRefPubMed
22.
go back to reference Caserta CA, Pendino GM, Amante A, Vacalebre C, Fiorillo MT, Surace P et al (2010) Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy. Am J Epidemiol 171:1195–1202CrossRefPubMed Caserta CA, Pendino GM, Amante A, Vacalebre C, Fiorillo MT, Surace P et al (2010) Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy. Am J Epidemiol 171:1195–1202CrossRefPubMed
23.
go back to reference Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J et al (2005) Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11:1848–1853CrossRefPubMedPubMedCentral Volzke H, Robinson DM, Kleine V, Deutscher R, Hoffmann W, Ludemann J et al (2005) Hepatic steatosis is associated with an increased risk of carotid atherosclerosis. World J Gastroenterol 11:1848–1853CrossRefPubMedPubMedCentral
26.
go back to reference Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291:1238–1245CrossRefPubMed Mokdad AH, Marks JS, Stroup DF, Gerberding JL (2004) Actual causes of death in the United States, 2000. JAMA 291:1238–1245CrossRefPubMed
28.
go back to reference Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L et al (2006) Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 29:1325–1330CrossRefPubMed Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L et al (2006) Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 29:1325–1330CrossRefPubMed
29.
go back to reference Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A et al (2013) A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis 230:258–267CrossRefPubMed Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A et al (2013) A systematic review: burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; should we care? Atherosclerosis 230:258–267CrossRefPubMed
30.
go back to reference Kim HC, Kim DJ, Huh KB (2009) Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 204:521–525CrossRefPubMed Kim HC, Kim DJ, Huh KB (2009) Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis 204:521–525CrossRefPubMed
31.
go back to reference Kang JH, Cho KI, Kim SM, Lee JY, Kim JJ, Goo JJ et al (2012) Relationship between nonalcoholic fatty liver disease and carotid artery atherosclerosis beyond metabolic disorders in non-diabetic patients. J Cardiovasc Ultrasound 20:126–133CrossRefPubMedPubMedCentral Kang JH, Cho KI, Kim SM, Lee JY, Kim JJ, Goo JJ et al (2012) Relationship between nonalcoholic fatty liver disease and carotid artery atherosclerosis beyond metabolic disorders in non-diabetic patients. J Cardiovasc Ultrasound 20:126–133CrossRefPubMedPubMedCentral
32.
go back to reference Stolic R, Trajkovic G, Jovanovic A, Stolić D, Perić V, Sovtić S et al (2010) Carotid ultrasonographic parameters as markers of atherogenesis and mortality rate in patients on hemodialysis. Vojnosanit Pregl 67:916–922CrossRefPubMed Stolic R, Trajkovic G, Jovanovic A, Stolić D, Perić V, Sovtić S et al (2010) Carotid ultrasonographic parameters as markers of atherogenesis and mortality rate in patients on hemodialysis. Vojnosanit Pregl 67:916–922CrossRefPubMed
33.
go back to reference Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H et al (2007) Nonalcolholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 13:1579–1584CrossRefPubMedPubMedCentral Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H et al (2007) Nonalcolholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 13:1579–1584CrossRefPubMedPubMedCentral
34.
35.
go back to reference Al-Nimer MS, Hussein II (2009) Increased mean carotid intima media thickness in type 2 diabetes mellitus patients with non-blood pressure component metabolic syndrome: a preliminary report. Int J Diabetes Dev Ctries 29:19–22CrossRefPubMedPubMedCentral Al-Nimer MS, Hussein II (2009) Increased mean carotid intima media thickness in type 2 diabetes mellitus patients with non-blood pressure component metabolic syndrome: a preliminary report. Int J Diabetes Dev Ctries 29:19–22CrossRefPubMedPubMedCentral
36.
go back to reference Mikolasevic I, Lukenda V, Racki S, Milic S, Sladoje-Martinovic B, Orlic L (2014) Nonalcoholic fatty liver disease (NAFLD)—a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients. Clin Interv Aging 9:1295–1303. doi:10.2147/CIA.S65382 CrossRefPubMedPubMedCentral Mikolasevic I, Lukenda V, Racki S, Milic S, Sladoje-Martinovic B, Orlic L (2014) Nonalcoholic fatty liver disease (NAFLD)—a new factor that interplays between inflammation, malnutrition, and atherosclerosis in elderly hemodialysis patients. Clin Interv Aging 9:1295–1303. doi:10.​2147/​CIA.​S65382 CrossRefPubMedPubMedCentral
37.
go back to reference Postorino M, Marino C, Tripepi G, Zoccali C (2008) Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. Kidney Int 74(Suppl 111):S64–S66CrossRef Postorino M, Marino C, Tripepi G, Zoccali C (2008) Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. Kidney Int 74(Suppl 111):S64–S66CrossRef
39.
go back to reference Dowman JK, Tomlinson JW, Newsome PN (2011) Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 33:525–540CrossRefPubMed Dowman JK, Tomlinson JW, Newsome PN (2011) Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Aliment Pharmacol Ther 33:525–540CrossRefPubMed
Metadata
Title
Correlation between nonalcoholic fatty liver and cardiovascular disease in elderly hemodialysis patients
Authors
Radojica V. Stolic
Goran Z. Trajkovic
Mirjana M. Kostic
Sasa R. Sovtic
Andrijana M. Odalovic
Biljana D. Krdzic
Maja V. Sipic
Snezana Lazic
Zorica N. Sojevic-Timotijevic
Publication date
01-06-2016
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 6/2016
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-016-1237-8

Other articles of this Issue 6/2016

International Urology and Nephrology 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.